Medical Marijuana, Inc. Portfolio Company KannaLife Sciences Covered by International Press for Signing New License With NIH to Develop Treatment for CTE Using Medicinal Marijuana

From the US to Turkey, the world is "buzzing" with the news that the National Institutes of Health, a U.S. Government Agency division of the Department of Health and Human Services, has approved KannaLife's drug discovery plan for using cannabis as the source for a new drug that will treat a concussion syndrome called Chronic Traumatic Encephalopathy or "CTE."
http://bit.ly/1uWHxoU